Concord Drugs informs about compliance certificate

14 Oct 2025 Evaluate

Concord Drugs has informed that it enclosed the Certificate from Registrar and Share Transfer Agent (R&T Agent) - Aarthi Consultants under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Concord Drugs for the quarter ended 30th September, 2025.

The above information is a part of company’s filings submitted to BSE.

Concord Drugs Share Price

76.77 2.52 (3.39%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×